P2.14-62 Early, Subclinical SCLC Transformation in Patients with EGFR Mutant Lung Cancer Receiving Osimertinib, Detected Through Cell-Free DNAE. Stewart, S. Martins-Filho,M. Cabanero, A. Wang,J. Huang,H. Bao,X. Wu,D. Patel,Z. Chen,J. Law,P. Bradbury,F. Shepherd,N. Leighl,M. Tsao,T. Pugh,S. Bratman,G. Liu,A. SacherJOURNAL OF THORACIC ONCOLOGY(2019)引用 0|浏览68暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络